Christine Dahlke

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 404 citations · Full text

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Till Koch, Christine Dahlke, Anahita Fathi et al. · The Lancet Infectious Diseases · 2020 · 166 citations · Full text

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV

Anne Rechtien, Laura Richert, Hadrien Lorenzo et al. · Cell Reports · 2017 · 122 citations · Full text

Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

Stefanie Ehrhardt, Matthias Zehner, Verena Krähling et al. · Nature Medicine · 2019 · 121 citations · Full text

Vaccination, Vaccine Development, Immunology +6

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization

Christine Dahlke, Rahel Kasonta, Sebastian Lunemann et al. · EBioMedicine · 2017 · 77 citations · Full text